Pharmaceutical Executive
With legislation pending in Congress, generics makers begin investments in follow-on protein drugs.
Pharmaceutical Executive-04-18-2007
- News
- Academy
- Multimedia
- Conferences
- Publications
- Partner Perspectives
- Resources
- Subscribe